Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Needle-Free Injectors Market Overview (2022-2032)

[250 Pages Report] Global demand for Needle-Free Injectors is expected to rise at a yearly growth rate of 12% Y-o-Y to US$ 42.79 Billion in 2032, supported by:

  • Growing emphasis on advanced and effective treatment approaches to boost global sales
  • Intensifying cases of transmitting diseases in the recent past have compelled pharma companies to introduce new quality products
  • Use of advanced materials in manufacturing Needle-Free Injectors for the treatment of chronic diseases to offer robust growth prospects.
  • Despite several advantages, limitations with large volume and intravenous administration systems like higher manufacturing costs impede the market growth

During the period ranging from 2020 to 2022, needle-free Injectors demand prospects appeared limited, attributed to the onset of transmittable diseases in the past, which emerged as a major roadblock.

Sales of needle-free injectors are estimated to accelerate significantly, attributed to the growing incidence of needle stick injuries and the rise in the number of parenteral drug approvals. People working with hypodermic syringes and other needle equipment are at a greater risk of needle stick injuries.

Continuing trends in the hypodermic needles market have restated the budding role of automated systems for needle creators for inspection and testing processes. According to the CDC, some 385,000 healthcare workers accidentally stick themselves with needles every year.

Needlestick injuries have the potential to transmit infectious diseases such as hepatitis B, hepatitis C, and human immunodeficiency virus (AIDS) among healthcare workers. As per this report, demand for Needle-Free Injectors for automotive production is expected to surge at over 12% CAGR until 2032.

Data Points Key Statistics
Estimated Value of Global Needle-Free Injectors Market by 2032 US$ 42.79 Billion
Documented Market Value of Needle-Free Injectors Market in 2022 US$ 13.78 Billion
Estimated CAGR from 2022-2032 12%
Estimated CAGR of APEJ by 2032 11.8%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Increasing Adoption Of Modern Tools In Healthcare Industry To Provide A Strong Base For Needle-Free Injectors Manufacturers In The Asia Pacific

The Asia Pacific is anticipated to yield significant growth opportunities, backed by robust healthcare infrastructure and favorable government regulations. By 2032-end, the annual growth rate is projected to encircle 12%, affected by several aspects. Within the Asia Pacific, the rapidly developing healthcare industry in China, is attributed to the increasing geriatric population and rising life expectancy.

Thereby, several pharma companies in China are making hefty investments in the development of innovative treatments for chronic diseases like cancer, diabetes, etc. These approaches are supporting the expansion of private-sector hospitals & clinics which sets a strong base for the development of needle-free injectors.

Likewise, India is expected to offer numerous growth opportunities for pharma companies, due to increasing emphasis on better healthcare treatment and promising growth in the healthcare sector in the country.

Opportunities Abound In The Cosmetic Surgeries Segment

In terms of market bifurcation, needle-free injectors have experienced the highest traction in the cosmetic surgeries segment. Based on the growing trends, this segment is estimated to register a CAGR of 12.1% over the years to come.

Given the technological advancements in recent years, a significant shift in the adoption of cosmetic surgeries for skin whitening, and body marks removal has been observed. Earlier, the high cost of surgeries impeded market growth. However, the introduction of innovative tools like needle-free injectors has supported global acceptance.

Needle-free injection technology (NFIT) is an exceptionally broad concept that includes an extensive array of drug delivery systems that drive drugs through the skin. This technology is not only touted to be valuable for the pharma industry but the developing world to find it highly useful in mass immunization programs, avoiding the chances of needle stick injuries and ducking other complications including those arising due to multiple uses of a single needle.

Growth of the needle-free injectors market can be attributed to faster drug delivery and increasing demand of the same from the healthcare sector. The market for needle-free injectors registered a CAGR of 8% in the historical period 2017-2021.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

2017-2021 Needle-Free Injectors Demand Outlook Compared To 2022-2032 Forecast

The global demand for electric guitars is projected to increase at a CAGR of 12% during the forecast period between 2022 and 2032, reaching a total of US$ 42.79 Billion in 2032, according to a report from Future Market Insights (FMI). From 2017 to 2021, sales witnessed significant growth, registering a CAGR of 8%.

Sales of needle-free injectors market increased considerably increased over the last few years due to factors such as the growing incidence of needle stick injuries and rise in the number of parenteral drugs approvals. People working with hypodermic syringes and other needle equipment are at a greater risk of needle stick injuries.

These injuries can mainly occur when people use or dispose needles. Hence, demand for needle-free injectors increased as they are the best alternative for patients and healthcare workers to prevent themselves from needle stick injuries.

Also, needle-free injectors offer faster drug delivery which enhances bioavailability as compared to invasive drug delivery systems. This is resulting in the increasing adoption of needle-free injectors.

Which Are Some Prominent Drivers Of Needle-Free Injectors Market?

Pharmaceutical industries propelling growth of needle-free injectors

Pharmaceutical industries are increasing the adoption of needle-free injectors as need for drug delivery or vaccinations is increasing. Needle-free injectors are preferred over invasive drug delivery systems as they don’t cause side-effects such as pain, swelling, or wounds.

Additionally, needle-free injectors are cost-effective, sanitary, fast, and nearly painless. Hence, key players are capitalizing on these benefits to increase their sales in countries with the weaker economic system. Need for needle-free insulin delivery as a primary treatment option has surged due to the rising prevalence of diabetes and insulin across the globe.

Growth of plastic surgeries increasing dependency on needle-free injectors

Alongside this, application of needle-free injectors in cosmetic industry is accelerating at a mounting pace. As per FMI, the cosmetics segment is projected to report maximum growth at a CAGR of 12.6% during the forecast period.

According to the American Society of Plastic Surgeons, 15.6 Billion cosmetic procedures took place in the world, among which 2.3 Billion are cosmetic surgical procedures and 13.2 Billion are cosmetic minimally-invasive procedures.

Hence, the demand for minimally invasive procedures is more as compared to invasive procedures. Driven by this, needle-free injectors manufacturers are increasing the adoption, generating ample of growth opportunities within cosmetic industry.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

What Are The Challenges Faced By The Needle-Free Injectors Market?

High Operating Cost of Needle-Free Injectors to Act as a Barrier for Key Players

Key players are facing difficulties in needle-free injectors manufacturing due to high cost and requirement of complex equipment. Difficulty in procuring certification for needle free injectors and need for sterilization before each batch of production also are proving to be challenges for market players.

Key players often have to spend on high operating costs to meet the aforementioned requirements for manufacturing of needle-free injectors, which also is expected to act as a challenge to growth. Besides this, the easy availability of needle-free injectors alternatives is restraining the market growth during the forecast period.

Region-Wise Insights

Prevalence of Chronic Diseases Augmenting Demand for Needle-Free Injectors in the U.S.?

Minimally invasive diagnostic care favoring growth of needle-free injectors

As per Future Market Insights, the U.S. is expected to be a leading market across North America, accounting for over 94.0% of the market in 2022. It is expected to continue exhibiting high demand for needle-free injectors through the course of the report’s assessment period.

Growth in the market is primarily driven by the rising prevalence of chronic diseases such as diabetes, cancer, and others. With goring preference for non-invasive and minimally-invasive diagnostic care, the adoption of needle-free injectors have increased, especially among home-care patient.

According to Centers for Disease Control and Prevention (CDC), in 2018, approximately 34.2 Billion cases of diabetes were found with the U.S. With the rising prevalence of diabetes, demand for needle-free injectors will accelerate, especially within geriatric population.

Increasing healthcare expenditure Creating Lucrative Opportunities for Needle-Free Injectors in Germany?

Key players expanding presence by increasing production units

According to the study, Germany is expected to dominate the Europe, holding 29.4% Europe’s market share through 2032. Increasing expenditure in healthcare due to rising awareness among consumers has encouraged them to spend on quality wellness products.

This has led to the surge in needle-free injectors’ adoption due to their ability of faster drug delivery and minimal invasion. Germany is considered to have the highest expenditure on its healthcare system, contributing approximately 11% of the GDP in 2018, according to Eurostat.

Alongside this, the presence of key players in the country and development of their product portfolio is also aiding the market growth. For instance, Gerresheimer Regensburg announced the expansion of its production unit for small batch production of plastics in Wackersdorf, Bavaria, Germany in November 2020.

Cosmetic Surgeries Bolstering Demand for Needle-Free Injectors in Japan?

Technological advancements supporting the use of needle-free injectors in the country

Japan is projected to hold over 34% share in the East Asia market, exhibiting growth at a CAGR of 11.7% during the forecast period. This is predominantly due to the rising cosmetic procedures in the country and technological advancements in healthcare and cosmetic industry.

For instance, according to International Survey on Aesthetic/Cosmetic Procedures Performed in 2018, there were total 224,293 surgical procedures took place in Japan that fuel the market of needle-free injectors.

Government Approvals Leading to Growth of Needle-Free Injectors in China?

Growth hormones for children accelerating growth of needle-free injectors

In 2020, China led the East Asia market with more than 46.8% share and is projected to expand at a CAGR of 12.0% through 2032. This is mainly due to the need of daily dosage of hormones administration in children and easy regulations by government for approving innovative products.

For instance, the National Medical Products Administration approved needle-free injectors for sale on the domestic market in August, 2017 in China. Also, more than 7 Billion Chinese children need daily doses of growth hormone who suffer from dwarfism in China which also going to benefits the market.

Category-Wise Insights

Prevention of Material Clusters Pushing Sales of Needle-Free Injectors?

Reduction in production cycles elevating growth

In terms of load type, the projectile injections segment is expected to expand at a CAGR of 13.9% during the forecast period.

The segment is expected to gain popularity due to the ability for prevention of material clusters that reduces cycle times and as it supports the production of parts with variable and uneven diameters.

Cosmetic Industry Propelling the Growth of Spring-loaded Jet Injector Technology More Preferred?

Painless and minimally invasive cosmetic surgeries contributing to spring-loaded jet injector growth

Growth in this segment attributed due to its nature to penetrate the skin for delivering a drug or vaccine into subcutaneous, intradermal or intramuscular tissues by creating a narrow stream under high pressure.

Moreover, the increasing dependency on needle-free injectors in the cosmetic industry is contributing to the growth of spring-loaded injectors. Thus, based on technology type, the spring-loaded jet injector segment will dominate the market, holding 47.1% of the revenue share in 2022.

Drug Delivery in Healthcare Settings Augmenting Growth of Needle-Free Injectors?

Healthcare industry supporting growth of drug delivery

Rising prevalence of chronic diseases is expected to aid the segment growth. This also has created demand for needle-free injectors in the homecare setting. Increasing expenditure by the healthcare industry along with technological advancements is fueling the growth of needle-free injectors.

In terms of application, drug delivery is expected to hold the leading share in the market, accounting for 65.0% of the revenue share in 2022.

Diabetic Patients Increasing Growth of Reusable Needle-Free Injectors High in Demand?

Multiple drug delivery making reusable needle-free injectors popular

With 79.5% of the revenue share, reusable needle-free injectors are expected to dominate the market in 2022. Reusable needle-free injectors are gaining popularity because they can be reused multiple times for drug delivery to a single patient with maximum ease of use.

For example, insulin delivery to the diabetic patient can be done through reusable needle-free injectors for multiple times. This method is cost effective also which plays a prime role in driving its demand in the future.

Increase in Patient Pool Driving Growth of Needle-Free Injectors in Hospitals?

Prevalence of chronic diseases increasing dependency on needle-free injectors

Factors such as growing awareness about needle-free injectors, rising prevalence of chronic diseases, and advent of COVID-19 have expanded the patient-pool in hospitals. Moreover, nearly all healthcare industries are relying on needle-free injectors owing to the increasing number of patients facing different chronic diseases.

This has led to an increasing demand for needle-free injectors. Based on the end-user, hospitals are expected to be the primary end-user, accounting for over 33.4% market share during the forecast period.

Start-Up For Needle-Free Injectors Market

Few key players in the needle-free injectors market are Portal Instruments and NovaXS Biotech.

  • In March 2022, NovaXS Biotech has received investor support for its patented needle-free injector. The device possesses a cloud-based platform that collects patient information for physicians. Information such as injection time, frequency, dosage volume, and medication temperature are expected to help the physicians to understand the effects of the dosage on the patient.
  • Portal Instruments, a key player in the needle-free injectors is focusing on commercializing its needle-free injectors. Thus, the company is focusing on collaborating with different established needle-free injectors.

Market Competition

Key players in the needle-free injectors market are Gerresheimer AG, Pfizer Inc., Halozyme, CSL Limited (Seqirus UK Limited), Crossject, Portal Instruments, Ferring Pharmaceuticals, PharmaJet Inc., PenJet Corporation

Key players are focusing on the expansion of their brands in emerging regions and manufacturing the newly revised product. Manufacturers are also adopting a slew of expansion strategies such as acquisition, new product launches and approvals, agreements, partnerships, and collaborations to strengthen their market presence.

  • In August 2022, PharmaJet was selected by WHO for million+ polio vaccination campaigns in Pakistan. Through this, the company will provide needle-free vaccines to 2.7 million children.
  • In May 2022, Gerresheimer AG and Portal Instruments entered a strategic partnership to treat chronically ill patients with innovative needle-free drug delivery solution. Together the companies are focusing on offering painless experience of injections to patients.

Report Scope

Report Attribute Details
Market Value in 2022 US$ 13.78 Billion
Market Value in 2032 US$ 42.79 Billion
Growth Rate CAGR of 12% from 2022 to 2032
Base Year for Estimation 2021
Historical Data 2017-2021
Forecast Period 2022-2032
Quantitative Units Revenue in US$ Million and CAGR from 2022-2032
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segments Covered
  • Load
  • Technology
  • Delivery Site
  • Application
  • End User
  • Region
Regions Covered
  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa
Key Countries Profiled
  • USA
  • Canada
  • Brazil
  • Argentina
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC
  • South Africa
Key Companies Profiled
  • Gerresheimer AG
  • Pfizer Inc.
  • Halozyme
  • CSL Limited (Seqirus UK Limited)
  • Crossject
  • Portal Instruments
  • Ferring Pharmaceuticals
  • PharmaJet Inc.
  • PenJet Corporation
Customization Available Upon Request

Key Segments Profiled In The Needle-Free Injectors Market Industry Survey

Needle-Free Injectors Market by Load:

  • Needle-Free Injectors by Liquid Injections
  • Needle-Free Injectors by Powder Injections
  • Needle-Free Injectors by Projectile Injections

Needle-Free Injectors Market by Technology:

  • Needle-Free Injectors by Spring-loaded jet injector
  • Needle-Free Injectors by Battery-powered jet injector
  • Needle-Free Injectors by Gas-powered jet injector

Needle-Free Injectors Market by Delivery Site:

  • Needle-Free Injectors by Intra dermal injectors
  • Needle-Free Injectors by Intramuscular injectors
  • Needle-Free Injectors by Subcutaneous injectors

Needle-Free Injectors Market by Application:

  • Needle-Free Injectors by Drug Delivery
  • Needle-Free Injectors by Vaccines
  • Needle-Free Injectors by Cosmetic
  • Needle-Free Injectors by Others

Needle-Free Injectors Market by End User:

  • Needle-Free Injectors by Home Care Settings
  • Needle-Free Injectors by Long Term Care Centers

Needle-Free Injectors Market by Region:

  • North America Needle-Free Injectors Market
  • Latin America Needle-Free Injectors Market
  • Europe Needle-Free Injectors Market
  • East Asia Needle-Free Injectors Market
  • South Asia Needle-Free Injectors Market
  • Oceania Needle-Free Injectors Market
  • Middle East & Africa Needle-Free Injectors Market

Frequently Asked Questions

What is the anticipated growth of the needle-free injectors market until 2032?

FMI projects the global needle-free injectors market to expand at a 12% value CAGR by 2032

What is the estimated market value of needle-free injectors market expected in 2022?

The global needle-free injectors market is estimated at a market value of US$ 13.78 Billion

What is the estimated market value of needle-free injectors market expected in 2032?

The global needle-free injectors market is expected to garner a market value of US$ 42.79 Billion

Which region is forecast to be the most lucrative for needle-free injectors market growth?

U.S. is expected to be a leading market across North America, accounting for over 94.0% of the market in 2022

Which are some prominent needle-free injectors manufacturers?

Gerresheimer AG, Pfizer Inc., Halozyme, CSL Limited (Seqirus UK Limited), Crossject, Portal Instruments, Ferring Pharmaceuticals, PharmaJet Inc., PenJet Corporation are some prominent needle-free injectors manufacturers

What is the expected market share of Germany for needle-free injectors in the forecast period 2022-2032?

Germany is expected to dominate the Europe, holding 29.4% Europe’s market share through 2032

What is the expected market share of Japan for needle-free injectors in the forecast period 2022-2032?

Japan is projected to hold over 34% share in the East Asia market, exhibiting growth at a CAGR of 11.7% during the forecast period

Which type of technology is expected to hold the largest market share for needle-free injectors in the forecast period 2022-2032?

The spring-loaded jet injector segment will dominate the market, holding 47.1% of the revenue share in 2022.

Which type of end user is expected to hold the largest market share for needle-free injectors in the forecast period 2022-2032?

Hospitals are expected to be the primary end-user, accounting for over 33.4% market share during the forecast period.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side and Supply Side Trends

    1.3. Technology Roadmap

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Market Background

    4.1. Macro-Economic Factors

        4.1.1. Global Healthcare Outlook

        4.1.2. Per Capita Healthcare Expenditure Outlook

        4.1.3. Increased Cancer Research Funding

    4.2. Forecast Factors - Relevance & Impact

        4.2.1. Key Players Historical Growth

        4.2.2. Product Adoption Across Regions

        4.2.3. Product cost

        4.2.4. Technological Advancements

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

5. Market Context

    5.1. Product Adoption Analysis

    5.2. Key Strategies Followed By Manufacturers

    5.3. Application & Technology Assessment

    5.4. Regulatory Scenario

    5.5. Advantage and Disadvantage

    5.6. Limitations of hypodermic needles

6. COVID19 Crisis Analysis

    6.1. Current COVID19 Statistics and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. Current Economic Projection as compared to 2008 financial analysis

    6.4. COVID19 and Impact Analysis

        6.4.1. Revenue By Load

        6.4.2. Revenue By End User

        6.4.3. Revenue By Region

    6.5. 2021 Market Scenario

    6.6. Recovery Scenario – Short term, Midterm and Long Term Impact

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Opportunity Analysis, 2022-2032

8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Load

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) and Volume (units) Analysis By Load, 2017-2021

    8.3. Current and Future Market Size (US$ Mn) and Volume (units) Analysis and Forecast By Load, 2022-2032

        8.3.1. Liquid Injections

        8.3.2. Powder Injections

        8.3.3. Projectile Injections

    8.4. Market Attractiveness Analysis By Load

9. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Technology

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Technology, 2017-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2022-2032

        9.3.1. Spring-loaded jet injector

        9.3.2. Battery-powered jet injector

        9.3.3. Gas-powered jet injector

    9.4. Market Attractiveness Analysis By Technology

10. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Technology

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Technology, 2017-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2022-2032

        10.3.1. Spring-loaded jet injector

        10.3.2. Battery-powered jet injector

        10.3.3. Gas-powered jet injector

    10.4. Market Attractiveness Analysis By Technology

11. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Application

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Application, 2017-2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2032

        11.3.1. Drug Delivery

        11.3.2. Vaccines

        11.3.3. Cosmetic

        11.3.4. Others

    11.4. Market Attractiveness Analysis By Application

12. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Usage

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis By Usage, 2017-2021

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Usage, 2022-2032

        12.3.1. Reusable Needle Free Injectors

        12.3.2. Disposable Needle Free Injectors

    12.4. Market Attractiveness Analysis By Usage

13. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End User

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Mn) Analysis By End User, 2017-2021

    13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2032

        13.3.1. Hospitals

        13.3.2. Veterinary Hospitals

        13.3.3. Speciality Clinics

        13.3.4. Home Care Settings

        13.3.5. Others

    13.4. Market Attractiveness Analysis By End User

14. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    14.1. Introduction

    14.2. Historical Market (US$ Mn) and Volume (units) Analysis By Region, 2017-2021

    14.3. Current Market (US$ Mn) and Volume (units) Analysis and Forecast By Region, 2022-2032

        14.3.1. North America

        14.3.2. Latin America

        14.3.3. Europe

        14.3.4. East Asia

        14.3.5. South Asia

        14.3.6. Oceania

        14.3.7. Middle East and Africa (MEA)

    14.4. Market Attractiveness Analysis By Region

15. North America Market Analysis 2017-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    15.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        15.3.1. By Country

            15.3.1.1. U.S.

            15.3.1.2. Canada

        15.3.2. By Load

        15.3.3. By Technology

        15.3.4. By Delivery Site

        15.3.5. By Application

        15.3.6. By Usage

        15.3.7. By End user

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

16. Latin America Market Analysis 2017-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    16.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        16.3.1. By Country

            16.3.1.1. Brazil

            16.3.1.2. Mexico

            16.3.1.3. Argentina

            16.3.1.4. Rest of Latin America

        16.3.2. By Load

        16.3.3. By Technology

        16.3.4. By Delivery Site

        16.3.5. By Application

        16.3.6. By Usage

        16.3.7. By End user

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

17. Europe Market Analysis 2017-2021 and Forecast 2022-2032

    17.1. Introduction

    17.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    17.3. Market Value (US$ Mn) Forecast By Market Taxonomy2022-2032

        17.3.1. By Country

            17.3.1.1. Germany

            17.3.1.2. Italy

            17.3.1.3. France

            17.3.1.4. U.K.

            17.3.1.5. Spain

            17.3.1.6. Russia

            17.3.1.7. Rest of Europe

        17.3.2. By Load

        17.3.3. By Technology

        17.3.4. By Delivery Site

        17.3.5. By Application

        17.3.6. By Usage

        17.3.7. By End user

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

18. South Asia Market Analysis 2017-2021 and Forecast 2022-2032

    18.1. Introduction

    18.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    18.3. Market Value (US$ Mn) Forecast By Market Taxonomy2022-2032

        18.3.1. By Country

            18.3.1.1. India

            18.3.1.2. Thailand

            18.3.1.3. Indonesia

            18.3.1.4. Malaysia

            18.3.1.5. Rest of South Asia

        18.3.2. By Load

        18.3.3. By Technology

        18.3.4. By Delivery Site

        18.3.5. By Application

        18.3.6. By Usage

        18.3.7. By End user

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

19. East Asia Market Analysis 2017-2021 and Forecast 2022-2032

    19.1. Introduction

    19.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    19.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        19.3.1. By Country

            19.3.1.1. China

            19.3.1.2. Japan

            19.3.1.3. South Korea

        19.3.2. By Load

        19.3.3. By Technology

        19.3.4. By Delivery Site

        19.3.5. By Application

        19.3.6. By Usage

        19.3.7. By End user

    19.4. Market Attractiveness Analysis

    19.5. Key Market Participants - Intensity Mapping

20. Oceania Market Analysis 2017-2021 and Forecast 2022-2032

    20.1. Introduction

    20.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    20.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        20.3.1. By Country

            20.3.1.1. Australia

            20.3.1.2. New Zealand

        20.3.2. By Load

        20.3.3. By Technology

        20.3.4. By Delivery Site

        20.3.5. By Application

        20.3.6. By Usage

        20.3.7. By End user

    20.4. Market Attractiveness Analysis

    20.5. Key Market Participants - Intensity Mapping

21. Middle East and Africa Market Analysis 2017-2021 and Forecast 2022-2032

    21.1. Introduction

    21.2. Historical Market Value (US$ Mn) Trend Analysis By Value Taxonomy, 2017-2021

    21.3. Market Delivery Site (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        21.3.1. By Country

            21.3.1.1. GCC Countries

            21.3.1.2. Turkey

            21.3.1.3. South Africa

            21.3.1.4. Rest of Middle East and Africa

        21.3.2. By Load

        21.3.3. By Technology

        21.3.4. By Delivery Site

        21.3.5. By Application

        21.3.6. By Usage

        21.3.7. By End user

    21.4. Market Attractiveness Analysis

22. Key & Emerging Countries Market Analysis 2017-2021 and Forecast 2022-2032

    22.1. U.S. Market Analysis

        22.1.1. By Load

        22.1.2. By Technology

        22.1.3. By Delivery Site

        22.1.4. By Application

        22.1.5. By Usage

        22.1.6. By End user

    22.2. Canada Market Analysis

        22.2.1. By Load

        22.2.2. By Technology

        22.2.3. By Delivery Site

        22.2.4. By Application

        22.2.5. By Usage

        22.2.6. By End user

    22.3. Brazil Market Analysis

        22.3.1. By Load

        22.3.2. By Technology

        22.3.3. By Delivery Site

        22.3.4. By Application

        22.3.5. By Usage

        22.3.6. By End user

    22.4. Mexico Market Analysis

        22.4.1. By Load

        22.4.2. By Technology

        22.4.3. By Delivery Site

        22.4.4. By Application

        22.4.5. By Usage

        22.4.6. By End user

    22.5. U.K. Market Analysis

        22.5.1. By Load

        22.5.2. By Technology

        22.5.3. By Delivery Site

        22.5.4. By Application

        22.5.5. By Usage

        22.5.6. By End user

    22.6. Germany Market Analysis

        22.6.1. By Load

        22.6.2. By Technology

        22.6.3. By Delivery Site

        22.6.4. By Application

        22.6.5. By Usage

        22.6.6. By End user

    22.7. France Market Analysis

        22.7.1. By Load

        22.7.2. By Technology

        22.7.3. By Delivery Site

        22.7.4. By Application

        22.7.5. By Usage

        22.7.6. By End user

    22.8. Italy Market Analysis

        22.8.1. By Load

        22.8.2. By Technology

        22.8.3. By Delivery Site

        22.8.4. By Application

        22.8.5. By Usage

        22.8.6. By End user

    22.9. Spain Market Analysis

        22.9.1. By Load

        22.9.2. By Technology

        22.9.3. By Delivery Site

        22.9.4. By Application

        22.9.5. By Usage

        22.9.6. By End user

    22.10. China Market Analysis

        22.10.1. By Load

        22.10.2. By Technology

        22.10.3. By Delivery Site

        22.10.4. By Application

        22.10.5. By Usage

        22.10.6. By End user

    22.11. South Korea Market Analysis

        22.11.1. By Load

        22.11.2. By Technology

        22.11.3. By Delivery Site

        22.11.4. By Application

        22.11.5. By Usage

        22.11.6. By End user

    22.12. Malaysia Market Analysis

        22.12.1. By Load

        22.12.2. By Technology

        22.12.3. By Delivery Site

        22.12.4. By Application

        22.12.5. By Usage

        22.12.6. By End user

    22.13. India Market Analysis

        22.13.1. By Load

        22.13.2. By Technology

        22.13.3. By Delivery Site

        22.13.4. By Application

        22.13.5. By Usage

        22.13.6. By End user

    22.14. Indonesia Market Analysis

        22.14.1. By Load

        22.14.2. By Technology

        22.14.3. By Delivery Site

        22.14.4. By Application

        22.14.5. By Usage

        22.14.6. By End user

    22.15. Australia Market Analysis

        22.15.1. By Load

        22.15.2. By Technology

        22.15.3. By Delivery Site

        22.15.4. By Application

        22.15.5. By Usage

        22.15.6. By End user

    22.16. New Zealand Market Analysis

        22.16.1. By Load

        22.16.2. By Technology

        22.16.3. By Delivery Site

        22.16.4. By Application

        22.16.5. By Usage

        22.16.6. By End user

    22.17. GCC Countries Market Analysis

        22.17.1. By Load

        22.17.2. By Technology

        22.17.3. By Delivery Site

        22.17.4. By Application

        22.17.5. By Usage

        22.17.6. By End user

    22.18. Turkey Market Analysis

        22.18.1. By Load

        22.18.2. By Technology

        22.18.3. By Delivery Site

        22.18.4. By Application

        22.18.5. By Usage

        22.18.6. By End user

    22.19. South Africa Market Analysis

        22.19.1. By Load

        22.19.2. By Technology

        22.19.3. By Delivery Site

        22.19.4. By Application

        22.19.5. By Usage

        22.19.6. By End user

23. Competition Analysis

    23.1. Competition Dashboard

    23.2. Competition Benchmarking

    23.3. Competition Deep Dive (Tentative List)

        23.3.1. ASTS Enterprises (Aunt) Pty Ltd

            23.3.1.1. Overview

            23.3.1.2. Product Portfolio

            23.3.1.3. Profitability by Market Segments (Product/Channel/Regional)

            23.3.1.4. Sales Footprint

            23.3.1.5. Strategy Overview

                23.3.1.5.1. Marketing Strategy

                23.3.1.5.2. Product Strategy

                23.3.1.5.3. Channel Strategy

        23.3.2. Weston Medical

            23.3.2.1. Overview

            23.3.2.2. Product Portfolio

            23.3.2.3. Profitability by Market Segments (Product/Channel/Regional)

            23.3.2.4. Sales Footprint

            23.3.2.5. Strategy Overview

                23.3.2.5.1. Marketing Strategy

                23.3.2.5.2. Product Strategy

                23.3.2.5.3. Channel Strategy

        23.3.3. PharmaJet

            23.3.3.1. Overview

            23.3.3.2. Product Portfolio

            23.3.3.3. Profitability by Market Segments (Product/Channel/Regional)

            23.3.3.4. Sales Footprint

            23.3.3.5. Strategy Overview

                23.3.3.5.1. Marketing Strategy

                23.3.3.5.2. Product Strategy

                23.3.3.5.3. Channel Strategy

        23.3.4. Crossject

            23.3.4.1. Overview

            23.3.4.2. Product Portfolio

            23.3.4.3. Profitability by Market Segments (Product/Channel/Regional)

            23.3.4.4. Sales Footprint

            23.3.4.5. Strategy Overview

                23.3.4.5.1. Marketing Strategy

                23.3.4.5.2. Product Strategy

                23.3.4.5.3. Channel Strategy

        23.3.5. PenJet® Corporation

            23.3.5.1. Overview

            23.3.5.2. Product Portfolio

            23.3.5.3. Profitability by Market Segments (Product/Channel/Regional)

            23.3.5.4. Sales Footprint

            23.3.5.5. Strategy Overview

                23.3.5.5.1. Marketing Strategy

                23.3.5.5.2. Product Strategy

                23.3.5.5.3. Channel Strategy

        23.3.6. Caretek Medical

            23.3.6.1. Overview

            23.3.6.2. Product Portfolio

            23.3.6.3. Profitability by Market Segments (Product/Channel/Regional)

            23.3.6.4. Sales Footprint

            23.3.6.5. Strategy Overview

                23.3.6.5.1. Marketing Strategy

                23.3.6.5.2. Product Strategy

                23.3.6.5.3. Channel Strategy

        23.3.7. Pfizer

            23.3.7.1. Overview

            23.3.7.2. Product Portfolio

            23.3.7.3. Profitability by Market Segments (Product/Channel/Regional)

            23.3.7.4. Sales Footprint

            23.3.7.5. Strategy Overview

                23.3.7.5.1. Marketing Strategy

                23.3.7.5.2. Product Strategy

                23.3.7.5.3. Channel Strategy

        23.3.8. Halozyme, Inc.

            23.3.8.1. Overview

            23.3.8.2. Product Portfolio

            23.3.8.3. Profitability by Market Segments (Product/Channel/Regional)

            23.3.8.4. Sales Footprint

            23.3.8.5. Strategy Overview

                23.3.8.5.1. Marketing Strategy

                23.3.8.5.2. Product Strategy

                23.3.8.5.3. Channel Strategy

        23.3.9. InjexUK

            23.3.9.1. Overview

            23.3.9.2. Product Portfolio

            23.3.9.3. Profitability by Market Segments (Product/Channel/Regional)

            23.3.9.4. Sales Footprint

            23.3.9.5. Strategy Overview

                23.3.9.5.1. Marketing Strategy

                23.3.9.5.2. Product Strategy

                23.3.9.5.3. Channel Strategy

        23.3.10. Gaungzhou Medsinglong Medical Equipment Company Ltd.

            23.3.10.1. Overview

            23.3.10.2. Product Portfolio

            23.3.10.3. Profitability by Market Segments (Product/Channel/Regional)

            23.3.10.4. Sales Footprint

            23.3.10.5. Strategy Overview

                23.3.10.5.1. Marketing Strategy

                23.3.10.5.2. Product Strategy

                23.3.10.5.3. Channel Strategy

        23.3.11. Zogenix

            23.3.11.1. Overview

            23.3.11.2. Product Portfolio

            23.3.11.3. Profitability by Market Segments (Product/Channel/Regional)

            23.3.11.4. Sales Footprint

            23.3.11.5. Strategy Overview

                23.3.11.5.1. Marketing Strategy

                23.3.11.5.2. Product Strategy

                23.3.11.5.3. Channel Strategy

        23.3.12. D'Antonio Consultants International, Inc.

            23.3.12.1. Overview

            23.3.12.2. Product Portfolio

            23.3.12.3. Profitability by Market Segments (Product/Channel/Regional)

            23.3.12.4. Sales Footprint

            23.3.12.5. Strategy Overview

                23.3.12.5.1. Marketing Strategy

                23.3.12.5.2. Product Strategy

                23.3.12.5.3. Channel Strategy

        23.3.13. AcuShot Needle Free

            23.3.13.1. Overview

            23.3.13.2. Product Portfolio

            23.3.13.3. Profitability by Market Segments (Product/Channel/Regional)

            23.3.13.4. Sales Footprint

            23.3.13.5. Strategy Overview

                23.3.13.5.1. Marketing Strategy

                23.3.13.5.2. Product Strategy

                23.3.13.5.3. Channel Strategy

        23.3.14. InsuJet™

            23.3.14.1. Overview

            23.3.14.2. Product Portfolio

            23.3.14.3. Profitability by Market Segments (Product/Channel/Regional)

            23.3.14.4. Sales Footprint

            23.3.14.5. Strategy Overview

                23.3.14.5.1. Marketing Strategy

                23.3.14.5.2. Product Strategy

                23.3.14.5.3. Channel Strategy

        23.3.15. QS Medical Technology Co., Ltd

            23.3.15.1. Overview

            23.3.15.2. Product Portfolio

            23.3.15.3. Profitability by Market Segments (Product/Channel/Regional)

            23.3.15.4. Sales Footprint

            23.3.15.5. Strategy Overview

                23.3.15.5.1. Marketing Strategy

                23.3.15.5.2. Product Strategy

                23.3.15.5.3. Channel Strategy

        23.3.16. MIKA MEDICAL CO.

            23.3.16.1. Overview

            23.3.16.2. Product Portfolio

            23.3.16.3. Profitability by Market Segments (Product/Channel/Regional)

            23.3.16.4. Sales Footprint

            23.3.16.5. Strategy Overview

                23.3.16.5.1. Marketing Strategy

                23.3.16.5.2. Product Strategy

                23.3.16.5.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

Recommendations

Healthcare

Auto-Injectors Market

Published : September 2023

Healthcare

Contrast Media Injectors Market

Published : January 2023

Healthcare

Wearable Injectors Market

Published : January 2023

Healthcare

Needle-Free Vaccine Injectors Market

Published : August 2021

Explore Healthcare Insights

View Reports

Needle-Free Injectors Market